Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqCM - Nasdaq Real Time Price USD

BriaCell Therapeutics Corp. (BCTXW)

0.1610
+0.0360
+(28.80%)
As of 1:04:08 PM EDT. Market Open.

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Gadi Levin B.Com., C.A., CPA, M.B.A. CFO & Corporate Secretary 443k -- 1973
Dr. Giuseppe Del Priore M.D., M.P.H., MPH Chief Medical Officer 540.33k -- 1962

BriaCell Therapeutics Corp.

Bellevue Centre
Suite 300 235 -15th Street
West Vancouver, BC V7T 2X1
Canada
604-921-1810 https://briacell.com
Sector: 
Healthcare
Industry: 
Biotechnology

Description

BriaCell Therapeutics Corp., a clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted cell-based immunotherapy that is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer. The company is also developing Bria-OTS, a platform of personalized off-the-shelf cell-based immunotherapies, which is being evaluated in a Phase 1/2 clinical studies targeting breast cancer with extension to prostate cancer and other cancers. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.

Corporate Governance

BriaCell Therapeutics Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

Related Tickers

RNTX Rein Therapeutics Inc.
1.7900
-1.65%
 
IPHA Innate Pharma S.A.
1.9700
0.00%
 
IBOGF Universal Ibogaine Inc.
0.0177
-6.84%
 
T3X.F Telix Pharmaceuticals Limited
16.89
+6.93%
 
388870.KQ Pharos iBio Co., Ltd.
6,980.00
-3.06%
 
KTTAW Pasithea Therapeutics Corp.
0.0186
+12.43%
 
ADAG Adagene Inc.
1.3900
-2.80%
 
AAPG Ascentage Pharma Group Internat
25.56
+6.92%
 
GLMD Galmed Pharmaceuticals Ltd.
1.5800
-3.07%
 
LEXX Lexaria Bioscience Corp.
1.5700
-1.26%